Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dynavax Technologies Corp. (DVAX)
NASDAQ:DVAX
Dynavax (DVAX) Stock Price & Analysis
2,303 Followers
DVAX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.42 - $15.15
Previous Close$13.79
Volume105.76K
Average Volume (3M)1.56M
Market Cap
$1.77B
Enterprise Value$1.32B
Total Cash (Recent Filing)$720.42M
Total Debt (Recent Filing)$253.09M
Price to Earnings (P/E)35.9
Beta1.16
Next Earnings
Feb 27, 2024EPS Estimate
-$0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.38
Shares Outstanding129,260,850
10 Day Avg. Volume1,315,942
30 Day Avg. Volume1,555,217
Standard Deviation0.25
R-Squared0.09
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)2.96
Price to Sales (P/S)2.47
Price to Cash Flow (P/CF)14.30
P/FCF Ratio13.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.61
Enterprise Value/Gross Profit2.86
Enterprise Value/Ebitda26.40
Forecast
1Y Price Target
$26.67Price Target Upside95.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Dynavax News
Pre-EarningsDVAX Earnings this Week: How Will it Perform?
Ownership Overview
0.92% Insiders
25.69% Mutual Funds
50.93% Other Institutional Investors
22.46% Public Companies and
Individual Investors
DVAX FAQ
What was Dynavax Technologies Corp.’s price range in the past 12 months?
Dynavax Technologies Corp. lowest stock price was $9.42 and its highest was $15.15 in the past 12 months.
What is Dynavax Technologies Corp.’s market cap?
Currently, no data Available
When is Dynavax Technologies Corp.’s upcoming earnings report date?
Dynavax Technologies Corp.’s upcoming earnings report date is Feb 27, 2024 which is in 85 days.
How were Dynavax Technologies Corp.’s earnings last quarter?
Dynavax Technologies Corp. released its earnings results on Nov 02, 2023. The company reported $0.1 earnings per share for the quarter, beating the consensus estimate of -$0.038 by $0.138.
Is Dynavax Technologies Corp. overvalued?
According to Wall Street analysts Dynavax Technologies Corp.’s price is currently Undervalued.
Does Dynavax Technologies Corp. pay dividends?
Dynavax Technologies Corp. does not currently pay dividends.
What is Dynavax Technologies Corp.’s EPS estimate?
Dynavax Technologies Corp.’s EPS estimate is -$0.03.
How many shares outstanding does Dynavax Technologies Corp. have?
Dynavax Technologies Corp. has 129,260,850 shares outstanding.
What happened to Dynavax Technologies Corp.’s price movement after its last earnings report?
Dynavax Technologies Corp. reported an EPS of $0.1 in its last earnings report, beating expectations of -$0.038. Following the earnings report the stock price went up 1.066%.
Which hedge fund is a major shareholder of Dynavax Technologies Corp.?
Among the largest hedge funds holding Dynavax Technologies Corp.’s share is Fisher Asset Management LLC. It holds Dynavax Technologies Corp.’s shares valued at 25M.
---
Dynavax Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$26.67 (95.10% Upside)
$26.67 (95.10% Upside)
Blogger Sentiment
Bullish
DVAX Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 2.3M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.9%
Last 30 Days ▼ 3.2%
Last 30 Days ▼ 3.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
9.96%
12-Months-Change
Fundamentals
Return on Equity
11.06%
Trailing 12-Months
Asset Growth
-2.64%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Dynavax Technologies Corp.
Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the development and discovery of novel vaccines and immuno-oncology therapeutics. It focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.
---
Top 5 ETFs holding DVAX
Vanguard Total Stock Market ETF
$59.77M
Vanguard Health Care ETF
$6.25M
Vanguard Russell 3000 ETF
$122.36K
SPDR S&P 1500 Value Tilt ETF
$13.78K
Invesco S&P US Total Market ESG Tilt Index ETF Trust Units -CAD Hedged-
$55.73
Up to five ETFs with an Outperform Smart Score that hold DVAX. The ETFs are listed according to market value of DVAX within the ETF
---